Thus, obesity as well as metabolic syndrome are risk factors for both prostate cancer [65] as well as CRC, and both are linked to high IGF-1 levels, which in turn is associated with an increased risk of both prostate cancer and CRC [64, 66]. This evidence concerns the gene IGF1 and obesity due to melanocortin 4 receptor deficiency.